- Home
- GRAB vs MRNA Comparison
GRAB vs MRNA Comparison
Compare GRAB & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRAB
- MRNA
- Stock Information
- Founded
- GRAB 2012
- MRNA 2010
- Country
- GRAB Singapore
- MRNA United States
- Employees
- GRAB N/A
- MRNA N/A
- Industry
- GRAB Business Services
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GRAB Consumer Discretionary
- MRNA Health Care
- Exchange
- GRAB Nasdaq
- MRNA Nasdaq
- Market Cap
- GRAB 19.2B
- MRNA 16.0B
- IPO Year
- GRAB N/A
- MRNA 2018
- Fundamental
- Price
- GRAB $4.61
- MRNA $27.72
- Analyst Decision
- GRAB Buy
- MRNA Hold
- Analyst Count
- GRAB 9
- MRNA 20
- Target Price
- GRAB $5.84
- MRNA $54.82
- AVG Volume (30 Days)
- GRAB 31.2M
- MRNA 9.6M
- Earning Date
- GRAB 05-14-2025
- MRNA 05-01-2025
- Dividend Yield
- GRAB N/A
- MRNA N/A
- EPS Growth
- GRAB N/A
- MRNA N/A
- EPS
- GRAB N/A
- MRNA N/A
- Revenue
- GRAB $2,797,000,000.00
- MRNA $3,236,000,000.00
- Revenue This Year
- GRAB $24.38
- MRNA N/A
- Revenue Next Year
- GRAB $18.28
- MRNA $23.65
- P/E Ratio
- GRAB N/A
- MRNA N/A
- Revenue Growth
- GRAB 18.57
- MRNA N/A
- 52 Week Low
- GRAB $2.98
- MRNA $26.26
- 52 Week High
- GRAB $5.72
- MRNA $170.47
- Technical
- Relative Strength Index (RSI)
- GRAB 49.77
- MRNA 34.27
- Support Level
- GRAB $4.29
- MRNA $26.80
- Resistance Level
- GRAB $4.85
- MRNA $34.87
- Average True Range (ATR)
- GRAB 0.18
- MRNA 1.66
- MACD
- GRAB 0.01
- MRNA -0.61
- Stochastic Oscillator
- GRAB 57.14
- MRNA 15.24
About GRAB Grab Holdings Limited
Founded in 2012, Grab provides ride-sharing services, food and grocery delivery, and financial services (payments, consumer loans, and enterprise offerings) in eight Southeast-Asian countries through its mobile platform. The company partners with merchants and riders, connecting them with consumers while charging commission to both sides. Grab has a leading market share in and derives 89% of its revenue from its core businesses, ride-sharing and food delivery. Singapore and Malaysia contributed 58% of revenue as of end-2021. Grab's main competitors in Southeast Asia are Foodpanda and Gojek, the ride-sharing arm of GoTo. Its financial services business is still in its nascent stage and provides minimal revenue currently. The company now also generates advertising revenue.
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.